Ends At: 17/03/2018
Contact Email: email@example.com
Contact Phone: +61 3 8658 9530
Eradicate Cancer 2018 – Can advanced immunotherapy make it possible?
Immunotherapy is rapidly emerging as the core medical platform for the treatment of cancer.
More than “just another conference”
The outstanding program of national and international opinion leaders.
The conference title deliberately poses a provocative question and call to action.
Where are we at and how close we are to the all-important “cures”?
What are the latest technologies and clinical advances in immunotherapies for cancer?
- focus on CAR-T cells, checkpoint blockades, NK cell, TIL/TCR targeting, cytokine modifying responses, therapeutic antibodies
- best practice for gene editing of T cells and current strategies to rejuvenate and reconstruct the immune system of cancer patients.
- Highlight final session: The Summit: Eradicate Cancer with Immunotherapy – If money was no object…. What is needed? How can we do it? How can we deliver to patients? Will we win? Panel discussion with key opinion leaders from research, clinic, biotech, regulatory and Government sectors.
|Early bird and Oral Abstract Deadline||1 December 2017|
|Poster Abstract Deadline||31 January 2018|
|Eradicate Cancer 2018||15 March 2018|